Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies ...
Coherus BioSciences is shifting entirely to immuno-oncology, divesting its biosimilar business. LOQTORZI (Toripalimab) is central to the strategy, showing significant growth and potential. The company ...
In addition to the new division, Syantra announces new funding from both existing and new investors to further platform extensibility and commercialization CALGARY, AB, Sept. 4, 2025 /CNW/ - Syantra, ...
Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) annual meeting 2025 in Chicago, US – ...
Schistosomiasis is a neglected tropical disease affecting over 250 million people, mainly in Sub-Saharan Africa. It is caused by the helminth parasite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback